Clinical Trial

HILT in Greater Trochanteric Pain Syndrome

Study acronym: HILT-GTPS
Recruiting
View on ClinicalTrials.gov →
Summary
Greater Trochanteric Pain Syndrome (GTPS) is a common cause of lateral hip pain that can significantly impair daily activities and quality of life. Conservative treatments, including physical therapy modalities and injections, are considered first-line management. High-Intensity Laser Therapy (HILT) is a non-invasive modality with greater tissue penetration compared to low-level laser therapy and has shown promising results in musculoskeletal disorders; however, evidence in GTPS is limited. This study aims to evaluate the efficacy of HILT compared with a sham intervention in patients with GTPS, focusing on pain intensity, functional status, and quality of life.
Trial Details
NCT Number NCT07749066
Lead Sponsor Ankara Etlik City Hospital
Conditions Greater Trochanteric Pain Syndrome
Enrollment 64 participants
Start Date 2026-06-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-06